South Africa’s Competition Commission has referred pharmaceutical manufacturer Adcock Ingram’s hospital division to the Competition Tribunal for prosecution over alleged excessive pricing of kidney dialysis products. The referral, announced on 3 June 2026, targets Adcock Ingram Critical Care (AICC) and covers pricing for peritoneal dialysis and continuous renal replacement therapy (CRRT) products between July 2019 and June 2024. The commission…
Tag: Competition Act
-
Section 59 Investigation: CMS Promises Binding Fraud Code
South Africa’s medical schemes regulator says it will implement the recommendations of the Section 59 Investigation into alleged discrimination against black healthcare providers. The commitment was made during parliamentary scrutiny of stalled reforms linked to both the Section 59 process and the Health Market Inquiry (HMI). The Council for Medical Schemes (CMS) launched the investigation after complaints from black providers…